Evidence map›Paper›PMID 40242485›Full record

ReviewMaterials today. Bio2025

Artificial cells and biomimicry cells: A rising star in the fight against cancer.

Renata Faria Maia, Asma Sadat Vaziri, Mohammad-Ali Shahbazi, Hélder A Santos

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Renata Faria MaiaDepartment of Biomaterials and Biomedical Technology, The Personalized Medicine Research Institute (PRECISION), The University Medical Center Groningen (UMCG), University of Groningen, the Netherlands.
Asma Sadat VaziriDepartment of Biomaterials and Biomedical Technology, The Personalized Medicine Research Institute (PRECISION), The University Medical Center Groningen (UMCG), University of Groningen, the Netherlands.
Mohammad-Ali ShahbaziDepartment of Biomaterials and Biomedical Technology, The Personalized Medicine Research Institute (PRECISION), The University Medical Center Groningen (UMCG), University of Groningen, the Netherlands.
Hélder A SantosDepartment of Biomaterials and Biomedical Technology, The Personalized Medicine Research Institute (PRECISION), The University Medical Center Groningen (UMCG), University of Groningen, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biomimetic Artificial Cells (ACs) are engineered systems that mimic the properties and functions of natural cells, offering significant potential for biomedical applications. The performance and applicability of these synthetic constructs depend on the choice of materials and fabrication methods. Our review delves into the materials, fabrication techniques, and diverse applications of ACs, emphasizing their transformative impact on the field of cancer therapy as smart vehicles for drug delivery, immune system stimulation, cancer cell targeting to minimize off-target effects and maximizing therapeutic efficacy as well as

Indexed as

Artificial cellCancer therapyDrug deliveryNanotechnologyPrecision medicine

Identifiers

PMID40242485
PMCPMC12000744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.